Coca-Cola has struggled to integrate its $5.6 billion purchase of BodyArmor with Powerade, which led to more “disruption in the short-term” than expected, according to CEO James Quincey.
Body Armor’s sales declined in the latest quarter.
The Atlanta-based Coca-Cola is optimistic that BodyArmor will eventually complement Powerade, its other big offering in the sports-drink category, as it aims to better compete against industry heavyweight, Pepsi-owned Gatorade.
BodyArmor’s purchase is the largest acquisition in Coca-Cola’s history.
In 2018, Coca-Cola first paid an undisclosed sum for a 15% share in BodyArmor, which had revenues of around $250 million.
That amount increased to more than $1 billion in 2021 when it acquired the remaining shares of brand to increase the variety of beverages it offers.
Through the use of coconut water, low sodium and high potassium levels, the lack of artificial colors, and the addition of sugar in place of high fructose corn syrup, the fast-growing, healthier sports drink gained popularity among consumers.
The purchase of BodyArmor by Coca-Cola led to a big bet that the beverage would play a key role in building out its liquid offerings and repositioning the business into a “total beverage company.”
Coca-Cola’s U.S. sports-drink market share had slipped in recent months. Still, the Coke chief remains optimistic this year will be a turning point for BodyArmor.


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Washington Post Publisher Will Lewis Steps Down After Layoffs
From Messi to Mika Häkkinen: how top athletes can slow down time
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Trump Draws Cheers at Ryder Cup as U.S. Trails Europe After Opening Day
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Extreme heat, flooding, wildfires – Colorado’s formerly incarcerated people on the hazards they faced behind bars
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



